TNF and inflammatory bowel disease: Although corticosteroids and anti-TNF agents both have associated adverse effects, corticosteroids have a less favorable risk-benefit ratio for IBD.6,9,10 However, the protective role of anti-TNF agents against the harmful effects of corticosteroids, especially mortality, is less established among patients at the highest risk of medication adverse effects.